查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279777

2022-2029年全球迷幻药市场规模研究和预测，按药物类型、应用、分销渠道和区域分析。

Global Psychedelic Drugs Market Size study & Forecast, by Drug Type by Application, By Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

迷幻药，也被称为致幻剂，是一类改变感知、情绪和认知过程的精神活性物质。它们在思想、情绪和感官知觉方面产生深刻的变化，常常诱发意识的改变、神秘的体验和强烈的情感。迷幻药的常见例子包括LSD、迷幻蘑菇、麦司卡林、DMT和死藤水。由于政府倡议、联盟和与精神健康有关的认识计划以及迷幻药研发的上升等因素，迷幻药市场正在扩大。

在预测期内，市场扩张的主要驱动力之一是心理健康困难的普遍存在，这就需要使用迷幻药物来治疗焦虑和抑郁、精神病和某些类型的恐慌症等疾病。例如，根据《2022年美国心理健康状况》报告，与2021年的数据集相比，有严重重度抑郁症发作（MDE）的年轻人多了197,000人。因此，抑郁症发病率的上升助长了对迷幻药需求的上升，这反过来又刺激了预测期内的市场扩张。此外，产品批准的上升和迷幻药物研究中心的发展上升。此外，产品批准的增加和迷幻药研究中心的发展正在为市场创造一个有利的增长。然而，在2022-2029年的预测期内，迷幻药的高副作用和严格的药物营销监管框架抑制了市场的增长。

全球迷幻药市场研究考虑的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于品牌产品的主导地位和该地区日益增长的疾病流行率，北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长，这是因为目标人群不断增加，合作开发产品的数量增加，主要参与者的地理扩张，以及政府和非营利组织在市场空间的积极参与等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，以及对主要参与者的竞争格局和药物类型产品的详细分析。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球和细分市场的估计和预测
    • 2019-2029年，按地区分類的迷幻药市场
    • 2019-2029年，按药物类型分類的迷幻药市场
    • 2019-2029年迷幻药市场，按应用划分
    • 2019-2029年，按分销渠道分類的迷幻药市场
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球迷幻药市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球迷幻药市场动态

  • 迷幻药市场影响分析（2019-2029年）
    • 市场驱动力
      • 与心理健康有关的政府倡议、联盟和宣传计划。
      • 迷幻药物的研究和开发的上升。
    • 市场挑战
      • 迷幻药的大量副作用
      • 严格的药物营销监管框架
    • 市场机会
      • 产品获批数量增加
      • 迷幻药研究中心的不断发展

第四章：全球迷幻药市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球迷幻药市场，按药物类型划分

  • 市场简介
  • 按药物类型分類的全球迷幻药市场，性能-潜力分析
  • 2019-2029年全球迷幻药市场按药物类型的估计和预测
  • 迷幻药市场，細項分析
    • γ-羟丁酸（GHB）
    • 氯胺酮
    • 迷幻药（Psilocybin
    • 麦角酸二乙胺(LSD)
    • 3,4-甲基乙二氧基甲基苯丙胺
    • 其他药物类型

第7章 ：全球迷幻药市场，按应用分类

  • 市场简介
  • 按应用分类的全球迷幻药市场，表现 - 潜力分析
  • 2019-2029年全球迷幻药市场按应用的估计和预测
  • 迷幻药市场，次级細項分析
    • 耐受治疗的抑郁症
    • 鸦片剂成瘾
    • 创伤后应激障碍
    • 嗜睡症
    • 恐慌症
    • 其他应用

第八章：全球迷幻药市场，按分销渠道划分

  • 市场简介
  • 按分销渠道分類的全球迷幻药市场，表现 - 潜力分析
  • 2019-2029年全球迷幻药市场按分销渠道的估计和预测
  • 迷幻药市场，次级細項分析
    • 医院药房
    • 零售药店
    • 其他分销渠道

第九章：全球迷幻药市场，区域分析

  • 迷幻药市场，区域市场简介
  • 北美洲
    • 美国。
      • 2019-2029年药物类型细分的估计和预测
      • 2019-2029年，应用细分的估计和预测
      • 2019-2029年，分销渠道细分的估计和预测
    • 加拿大
  • 欧洲迷幻药市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区迷幻药市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲迷幻药市场简况
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 世界其他地区

第十章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Jazz Pharmaceuticals
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • NeonMind BioSciences
    • Cybin Corp.
    • Pfizer Inc.
    • Numinus
    • Mind Medicine
    • PharmaTher Holdings Ltd
    • NRx Pharmaceuticals Inc.
    • Seelos Therapeutics
    • Havn Life

第十一章 ：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Psychedelic Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psychedelic drugs, also known as hallucinogens, are a class of psychoactive substances that alter perception, mood, and cognitive processes. They produce profound changes in thought, mood, and sensory perception, often inducing altered states of consciousness, mystical experiences, and intense emotions. Common examples of psychedelic drugs include LSD, psilocybin mushrooms, mescaline, DMT, and ayahuasca. The Psychedelic Drugs market is expanding because of factors such as government initiatives, alliances, and awareness programs associated with mental health and rise in research and development of psychedelic drugs.

One of the main drivers of market expansion during the forecast period is the prevalence of mental health difficulties, which call for the use of psychedelic medications to treat conditions like anxiety and depression, psychosis, and some types of panic attacks. For instance, according to the State of Mental Health in America 2022 report, there were 197,000 more young people who had a severe major depressive episode (MDE) than there were in the 2021 dataset. As a result, the rising prevalence of depressive disorders fuels a rise in the demand for psychedelic medications, which in turn spurs market expansion over the projection period. Furthermore, a rise in product approvals and rising development of psychedelic drugs research center. In addition, a rise in product approvals and rising development of psychedelic drugs research centre is creating a lucrative growth to the market. However, high number of side effects of psychedelic drug and stringent regulatory framework for drug marketing stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psychedelic Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Jazz Pharmaceuticals
  • NeonMind BioSciences
  • Cybin Corp.
  • Pfizer Inc.
  • Numinus
  • Mind Medicine
  • PharmaTher Holdings Ltd
  • NRx Pharmaceuticals Inc.
  • Seelos Therapeutics
  • Havn Life

Recent Developments in the Market:

  • In October 2022, Numinus Wellness Inc., a supplier of mental health services that promotes new treatments and safe, evidence-based psychedelic-assisted therapies, launched the Ketamine for Chronic and Serious Medical Illness Programme. This new initiative will likely debut at the Numinus clinics in Utah, British Columbia, and Quebec. The company will expand the scheme to more clinics in the upcoming months.
  • In March 2022, University of California researchers published the findings and follow-up information from a phase 3 clinical trial using the psychedelic substance 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy to treat post-traumatic stress disorder (PTSD). Their preliminary findings suggested that the therapy is effective even for people who are difficult to treat, like those who have drug or alcohol use disorders.

Global Psychedelic Drugs Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Type, Application, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Type offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

  • Gamma Hydroxybutyric Acid (GHB)
  • Ketamine
  • Psilocybin
  • Lysergic Acid Diethylamide (LSD),
  • 3,4-MethylEnedioxyMethamphetamine
  • Other Drug Types

By Application:

  • Treatment Resistant Depression
  • Opiate Addiction
  • Post-traumatic Stress Disorder
  • Narcolepsy
  • Panic Disorders
  • Other Applications

By Distribution Channel:

  • Hospital pharmacy
  • Retail pharmacy
  • Other Distribution Channels

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Psychedelic Drugs Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Psychedelic Drugs Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.3. Psychedelic Drugs Market, by Application, 2019-2029 (USD Billion)
    • 1.2.4. Psychedelic Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Psychedelic Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Psychedelic Drugs Market Dynamics

  • 3.1. Psychedelic Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Government initiatives, alliances, and awareness programs associated with mental health.
      • 3.1.1.2. Rise in Research and Development of Psychedelic Drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Number of Side Effects of Psychedelic Drug
      • 3.1.2.2. Stringent Regulatory Framework for Drug Marketing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. A rise in product approvals
      • 3.1.3.2. Rising development of psychedelic drugs research centre

Chapter 4. Global Psychedelic Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psychedelic Drugs Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Global Psychedelic Drugs Market by Drug Type, Performance - Potential Analysis
  • 6.3. Global Psychedelic Drugs Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 6.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 6.4.1. Gamma Hydroxybutyric Acid (GHB)
    • 6.4.2. Ketamine
    • 6.4.3. Psilocybin
    • 6.4.4. Lysergic Acid Diethylamide (LSD)
    • 6.4.5. 3,4- MethylEnedioxyMethamphetamine
    • 6.4.6. Other Drug Types

Chapter 7. Global Psychedelic Drugs Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Psychedelic Drugs Market by Application, Performance - Potential Analysis
  • 7.3. Global Psychedelic Drugs Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 7.4.1. Treatment Resistant Depression
    • 7.4.2. Opiate Addiction
    • 7.4.3. Post-traumatic Stress Disorder
    • 7.4.4. Narcolepsy
    • 7.4.5. Panic Disorders
    • 7.4.6. Other Applications

Chapter 8. Global Psychedelic Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Psychedelic Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Psychedelic Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Psychedelic Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospital pharmacy
    • 8.4.2. Retail pharmacy
    • 8.4.3. Other Distribution Channels

Chapter 9. Global Psychedelic Drugs Market, Regional Analysis

  • 9.1. Psychedelic Drugs Market, Regional Market Snapshot
  • 9.2. North America Psychedelic Drugs Market
    • 9.2.1. U.S. Psychedelic Drugs Market
      • 9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Psychedelic Drugs Market
  • 9.3. Europe Psychedelic Drugs Market Snapshot
    • 9.3.1. U.K. Psychedelic Drugs Market
    • 9.3.2. Germany Psychedelic Drugs Market
    • 9.3.3. France Psychedelic Drugs Market
    • 9.3.4. Spain Psychedelic Drugs Market
    • 9.3.5. Italy Psychedelic Drugs Market
    • 9.3.6. Rest of Europe Psychedelic Drugs Market
  • 9.4. Asia-Pacific Psychedelic Drugs Market Snapshot
    • 9.4.1. China Psychedelic Drugs Market
    • 9.4.2. India Psychedelic Drugs Market
    • 9.4.3. Japan Psychedelic Drugs Market
    • 9.4.4. Australia Psychedelic Drugs Market
    • 9.4.5. South Korea Psychedelic Drugs Market
    • 9.4.6. Rest of Asia Pacific Psychedelic Drugs Market
  • 9.5. Latin America Psychedelic Drugs Market Snapshot
    • 9.5.1. Brazil Psychedelic Drugs Market
    • 9.5.2. Mexico Psychedelic Drugs Market
    • 9.5.3. Rest of Latin America Psychedelic Drugs Market
  • 9.6. Rest of The World Psychedelic Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Jazz Pharmaceuticals
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. NeonMind BioSciences
    • 10.2.3. Cybin Corp.
    • 10.2.4. Pfizer Inc.
    • 10.2.5. Numinus
    • 10.2.6. Mind Medicine
    • 10.2.7. PharmaTher Holdings Ltd
    • 10.2.8. NRx Pharmaceuticals Inc.
    • 10.2.9. Seelos Therapeutics
    • 10.2.10. Havn Life

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Psychedelic Drugs Market, report scope
  • TABLE 2. Global Psychedelic Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Psychedelic Drugs Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 4. Global Psychedelic Drugs Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Psychedelic Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Psychedelic Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Psychedelic Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Psychedelic Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Psychedelic Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Psychedelic Drugs Market
  • TABLE 71. List of primary sources, used in the study of global Psychedelic Drugs Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Psychedelic Drugs Market, research methodology
  • FIG 2. Global Psychedelic Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Psychedelic Drugs Market, key trends 2021
  • FIG 5. Global Psychedelic Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Psychedelic Drugs Market, porters 5 force model
  • FIG 7. Global Psychedelic Drugs Market, pest analysis
  • FIG 8. Global Psychedelic Drugs Market, value chain analysis
  • FIG 9. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Psychedelic Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Psychedelic Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Psychedelic Drugs Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Psychedelic Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable